Kane Logo Cropped TransBG.png
Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 – Conference Call to Follow
August 18, 2022 16:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan
June 30, 2022 16:05 ET | Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 30, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Amended Credit Facility
June 15, 2022 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, June 15, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has further amended its credit agreement...
Kane Logo Cropped TransBG.png
Kane Biotech Announces First Quarter 2022 Financial Results
May 26, 2022 16:05 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 26, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow
May 19, 2022 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Obtains ISO 13485 Certification
May 18, 2022 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today that it has obtained ISO 13485:2016 certification...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Closing of Private Placement
May 17, 2022 07:00 ET | Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Update on Private Placement
May 06, 2022 08:30 ET | Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 06, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane...
Kane Logo Cropped TransBG.png
Kane Biotech Announces Extension of Private Placement Offering
April 29, 2022 16:05 ET | Kane Biotech Inc.
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, April 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane...
Kane Logo Cropped TransBG.png
STEM Animal Health Awarded Veterinary Oral Health Council (VOHC) Seal of Acceptance for Pet Oral Care Water Additive
April 07, 2022 12:40 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, April 07, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), is pleased to announce today that STEM Animal Health Inc....